Cannapharmarx Inc (CPMD) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
CannaPharmaRX, Inc. has entered into a three-year Supply Agreement with Israeli corporation D.N.S. Cantek 2019 Ltd., stipulating that Cantek will buy a minimum of 1,000 kg of the company’s products annually at $2.75 CDN per gram. The deal includes a most-favored nation clause ensuring Cantek receives the best pricing available and standard termination clauses. Shareholders and interested parties are encouraged to review the full details of the Supply Agreement for a comprehensive understanding.
For further insights into CPMD stock, check out TipRanks’ Stock Analysis page.
